A New York City law firm filed a securities class action lawsuit against spine devicemaker Orthofix Medical.

Stryker signed a definitive agreement to acquire Vertos Medical, a pain management company.

Globus Medical launched the Adira extreme lateral interbody fusion plate system, according to an Aug. 21 news release.

SI-Bone earned FDA 510(k) clearance and breakthrough device designation for the iFuse Torq TNT implant system, according to an Aug. 21 news release. 

Here are four key developments from spine and orthopedic medtech companies since Aug. 14.

On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff Martha credited one of the company's key product lines for spine growth in an Aug. 20 earnings call.

Medtronic posted $7.9 billion in sales for the first quarter of fiscal year 2025, according to an Aug. 20 news release.

At least four law firms have launched investigations into Globus Medical after the company received a warning letter from the FDA.

A judge has upheld a 2023 patent infringement verdict in favor of Globus Medical, according to Aug. 13 court documents filed in the U.S. District Court for the Eastern District of Pennsylvania.

From new acquisitions to FDA clearances, here are four updates from orthopedic devicemakers since Aug. 7.

Stryker signed a definitive agreement to acquire care.ai, a company developing artificial intelligence-assisted virtual care workflows and smart room technology. 

From implants to surgical techniques, national and commercial payers are updating their policies to expand access to spine care.

Stryker, Johnson & Johnson and Zimmer Biomet posted their second-quarter financial results for 2024 and data on their spine orthopedic sales.

From financial updates to new Medicare policy, here are eight key updates from spine and orthopedic devicemakers since July 24.

Globus Medical saw net sales of $629.7 million in the second quarter, according to financial results posted Aug. 7.

The next step for Orthofix's 7D Flash navigation for spine is outpatient, CEO Massimo Calafiore said in an Aug. 6 earnings call.

Two Alphatec executives acquired more shares of company stock, according to Aug. 5 Securities and Exchange Commission filings. 

Two spine medtech companies secured financing to support their growth.

Orthofix saw second quarter sales rise year-over-year in the second quarter of 2024, according to financial results posted Aug. 6.

A second patient received a Neuralink implant, USA Today reported Aug. 5.